Marta Aldea
Impact in
- Health top 5%
- Vaccine Coverage and Hesitancy
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Health 7
- Vaccine Coverage and Hesitancy 6
-
- Influenza Virus Research Studies 4
- Co-authors
- Anna Llupià (6 shared papers)Guillermo Sequera (8 shared papers)Guillermo Mena (8 shared papers)Alberto L. García‐Basteiro (6 shared papers)Antoni Trilla (8 shared papers)Linda O'Neal Eckert (1 shared paper)David A. Ross (1 shared paper)Deborah Watson‐Jones (1 shared paper)
- Journals
- The Lancet (1 paper)Multiple Sclerosis Journal (1 paper)BMC Medical Education (1 paper)Infectious Diseases and Therapy (1 paper)Vaccine (1 paper)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Marta Aldea
27 papers receiving 752 citations
Marta Aldea's Hit Papers
Peers
Comparison fields: 5 of 89
- Health 138
- Infectious Diseases 296
- Pathology and Forensic Medicine 108
- Modeling and Simulation 22
- Neurology 61
Countries citing papers authored by Marta Aldea
This map shows the geographic impact of Marta Aldea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Aldea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Aldea more than expected).
Fields of papers citing papers by Marta Aldea
This network shows the impact of papers produced by Marta Aldea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Aldea. The network helps show where Marta Aldea may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Aldea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial Hit paper breakdown → | 2021 | 287 |
| 2 | 2016 | 89 | |
| 3 | 2017 | 87 | |
| 4 | 2015 | 80 | |
| 5 | 2013 | 33 | |
| 6 | 2021 | 30 | |
| 7 | 2013 | 29 | |
| 8 | 2012 | 26 | |
| 9 | 2018 | 25 | |
| 10 | 2015 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2011 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 2014 | 6 | |
| 16 | 2025 | 4 | |
| 17 | 2012 | 4 | |
| 18 | 2019 | 2 | |
| 19 | 2016 | 2 | |
| 20 | 2019 | 2 |
About Marta Aldea
Marta Aldea is a scholar working on Health, Epidemiology, Infectious Diseases, Pathology and Forensic Medicine and Family Practice, having authored 29 papers that have together received 770 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (6 papers), Influenza Virus Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Multiple Sclerosis Research Studies (2 papers), Colorectal Cancer Screening and Detection (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Health (138 citations), Infectious Diseases (296 citations), Pathology and Forensic Medicine (108 citations), Modeling and Simulation (22 citations) and Neurology (61 citations). Marta Aldea has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Anna Llupià, Guillermo Sequera, Guillermo Mena, Alberto L. García‐Basteiro, Antoni Trilla, Linda O'Neal Eckert, David A. Ross, Deborah Watson‐Jones, Katherine E. Gallagher and Sandra Mounier‐Jack. Their work appears in journals such as The Lancet, Multiple Sclerosis Journal, BMC Medical Education, Infectious Diseases and Therapy and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.